Document:

Exhibit 10.23

 

LICENSE AGREEMENT

 

This AGREEMENT, made as of August 28, 2013
by and between Donald Bittar., having a place of business at 1675 Saladino Street, Palm Bay, FL 32909 (hereinafter "Bittar");
and First Choice Healthcare Solutions, Inc., having an office at 709 S. Harbor City Blvd, Suite 250, Melbourne Florida 32901, United
States (hereinafter "FCHS")

 

WITNESSETH:

 

WHEREAS, Bittar owes owns certain rights
in and to U.S. Patent Number 7,789,842, filed on October 1, 2007, and entitled Adjustable Arm Sling;

 

WHEREAS, Bittar Seller is the sole legal
and beneficial owner of U.S. Patent Number 7,789,842 (Patent) and has good and marketable title to all of the rights for U.S. Patent
Number 7,789,842, free and clear of any and all claims, liens, encumbrances and security interests whatsoever.

 

WHEREAS, FCHS wishes to own the certain
rights in and to U.S. Patent Number 7,789,842, filed on October 1, 2007, and entitled Adjustable Arm Sling;

 

WHEREAS, Bittar has, on even date herewith,
assigned all of its rights and interest in and to the Patent Rights to FCHS (Assignment Agreement) in consideration of the execution
of the present License Agreement and is interested in agreeing to the specific terms and conditions of the license agreement with
FCHS with respect to the Patent Rights;

 

WHEREAS, the parties which to exploit the
intellectual rights and/or to grant to third parties, royalty-bearing licenses under the intellectual property;

 

NOW, THEREFORE, in consideration of the
covenants and premises hereafter recited and of other good and valuable consideration, the receipt of which is acknowledged, the
parties thereto hereby agree as follows:

 

		1.	Effective date: This License Agreement shall become effective
on the date hereof, and, unless sooner terminated as provided in Paragraph 11 hereof, shall continue until and shall expire on
the day of expiration of the last to expire patent included within the Patent Rights.

 

		2.	Market value: The fair market value of the Patent Rights has been appraised by Professional Business Brokers, an independent
valuation firm qualified in valuing medical practices, and the purchase price for the Purchased Membership Interests, which is
within the range determined by Professional Business Brokers, is $286,500 (Purchase Price). FCHS shall pay to Bittar the Purchase
Price in FCHS restricted, unregistered common stock of FCHS (Shares) at the rate of $.45 per Share that has a total market value
equal to the Purchase Price based on the closing price of the Shares on the date of the Agreement, herein. The Shares shall be
issued in the name of Donald Bittar and shall be subject to Rule 144 of the Securities Act of 1933 and other restrictions imposed
on unregistered shares of stock by Federal and Florida law, and the certificates representing the FCHS Shares shall contain a standard
Securities Exchange Act of 1934 restrictive legend.

 

		3.	Royalty: In the event that FCHS, or a licensee or sub-licensee of FCHS, manufactures, uses, and/or sells products to
or for a third party covered by the Patent Rights, a royalty shall accrue from FCHS to Bittar at the rate of five percent (5.0%)
of the net sales price of products sold by FCHS or its licensee.

As used herein, "net sales price" shall
mean the price charged by FCHS, or a third party licensee or sub-licensee of FCHS, reduced by any bona fide discount therefrom
actually allowed in the sale and by the costs of packaging and transportation to the customers. In no instance, however, shall
more than the single 5% royalty accrue hereunder for any product sold hereunder.

 

    	 

    	 

    

 

		4.	Payment period: FCHS shall pay to Bittar within thirty (30) days

		a.	after the last day in each June and December within the term hereof,

		b.	within two (2) months after the day of any termination of said term,

the running royalties which have accrued pursuant
to the Royalty Paragraph hereof during the preceding six (6) month period or so much thereof as is within said term ended.

 

		5.	Currency: All payments required hereunder to be made hereunder shall be made, to Bittar, in United States funds without
any deduction of any kind except necessary deduction (if any) which may be required by the tax laws of any country and which shall
be evidenced by appropriate official tax receipts furnished by the paying party. When the application of the provisions of this
agreement results in amounts of royalties expressed in currencies other than that of the United States, those amounts shall be
translated into equivalent amounts in United States currency at official New York exchange rates prevailing at the time of remittance
(or, if not paid when due, and if the receiving party shall so elect, then at such rates prevailing when due), and such equivalent
amounts shall be the amounts to be paid.

 

		6.	Record keeping: FCHS shall keep, and shall require its licensees and sub-licensees hereunder to keep, true books of
account containing an accurate and complete record of all data necessary for the computation and payment of the accruing running
royalties. FCHS shall furnish to Bittar a written royalty statement setting forth in reasonable detail for the computation of running
royalties then payable (if none, so stating) and the underlying facts on which such computation is based.

 

		7.	Audit: Bittar shall have the right, at his own expense, during the term hereof, to have an independent public accountant
examine the relevant books and records of the other party and its licensees and sub-licensees hereunder during normal business
hours not more than twice each calendar year to determine whether appropriate accounting and payment have been made hereunder.

 

		8.	Default: In the event of a substantial default
by FCHS with respect to any of its obligations hereunder, Bittar shall give FCHS written notice of the default, and if the same
be not remedied within sixty (60) days thereafter, Bittar may terminate this License Agreement by giving FCHS at least thirty
(30) days prior written notice of such termination, which shall be without prejudice to the pursuit of any other remedies as well
by Bittar. Forbearance by Bittar to invoke the provisions of the immediately preceding sentence with respect to any default or
defaults shall not imply a waiver thereof or of any other default. In the event this Agreement is terminated by Bittar, the Assignment
Agreement shall become null and void and Bittar's rights thereafter in the Patent Rights shall revert to being the sole owner
of the Patent Rights.

 

    	 

    	 

    

 

		9.	Patent fees and maintenance: FCHS shall be responsible to file, prosecute and maintain all documentation with respect
to the patent and pay all filing costs, prosecution costs, including reasonable attorney and agent fees, as well as the maintenance
fees for such patent.

 

		10.	Infringement: If, at any time during the term
hereof there be an infringement of the patent comprised in the Patent Rights, FCHS shall bring suit to suppress the infringement.
Bittar may receive a one third share of any settlement of such suit and damages and costs awarded in such suit.

 

		11.	Venue: This License Agreement shall be construed in accordance with the laws of the State of Florida, U.S.A but the
scope and validity of the patent comprised within the Patent Rights shall be governed by the applicable laws of the country granting
such patent. Both parties agree to submit to the jurisdiction and accept service of process by the Courts of the State of Florida
and the U.S. Federal District Court in Florida.

 

		12.	Commercialization: If at the end of three ( 3)
years from the date of this agreement FCHS fails to reasonably market and commercialize the Patent, Bittar shall have the right
to terminate this agreement after 90 days written notice to FCHS. In the event this Agreement is terminated by Bittar, the Assignment
Agreement shall become null and void and Bittar's rights thereafter in the Patent Rights shall revert to being the sole owner
of the Patent Rights.

 

		13.	Notices: Notices hereunder shall be in writing and shall be duly dispatched in the country of address of either party
by registered air mail duly addressed, if to

Bittar to: 1675 Saladino Street SE, Palm Bay, FL 32909

or, if to FCHS, to: First Choice Healthcare Solutions,
Inc., 709 Harbor City Blvd, Suite 250, Melbourne Florida 32901.

 

		14.	Embodiment: This License Agreement embodies all of the understanding and obligations between the parties concerning
the subject matter hereof. Any amendments and supplements hereto shall be valid only if executed in writing by an authorized officer
of FCHS and Bittar. This License Agreement shall be assignable by either party only with the written consent of the other part,
which consent shall not be unreasonable withheld.

 

IN WITNESS WHEREOF, the parties have caused
this License Agreement to be executed as of the date hereof first set forth.

 

	Donald Bittar	First Choice Healthcare Solutions, Inc.

 

 

	/s/ Donald Bittar	/s/ Christian C. Romandetti

	Donald Bittar	By: Christian C. Romandetti

President

 

    	 

    	 

    

 

PATENT ASSIGNMENT

 

WHEREAS, Donald Bittar, having an office
at 1675 Saladino Street SE Palm Bay, Florida 32909 (hereinafter Bittar) owns certain rights in and to U.S. Patent Number 7,789,842,
filed on October 1, 2007 and entitled Adjustable Arm Sling;

 

WHEREAS First
Choice Healthcare Solutions Inc., a Delaware corporation, having an office at 790 Harbor City Blvd Suite 250, Melbourne,
Florida, 32909, United State (hereinafter "FCHS"), is desirous of obtaining the entire rights of Bittar in, to and
under the said patent application:

 

WHEREAS Bittar and
FCHS are, on even date herewith, entering into a License Agreement under which Bittar is granted certain rights under said patent
application and its foreign counterparts, and

 

NOW, THEREFORE, in
consideration of the execution of the aforesaid License Agreement between Bittar and FCHS, and other good and valuable consideration,
the receipt of which is hereby acknowledged, Bittar does hereby sell, assign, transfer and set over, unto the said FCHS, its entire
right, title and interest in, to and under the said patent application and all divisions, renewals and continuations thereof, and
all Letters Patent of the United States have been granted thereon and Bittar hereby authorizes and requests the Commissioner of
Patents of the United States, and any Official of any country or countries foreign to the United States, whose duty it is to issue
patents on applications as aforesaid, to issue all Letters Patent covered herein to the said FCHS, in accordance with the terms
of this instrument.

 

This assignment is
subject to the terms and conditions of the aforesaid License Agreement between FCHS and Bittar and this Assignment may be transferred
or reassigned by FCHS only to a third party that has executed a License Agreement with Bittar under the patent rights herein transferred.
Any assignment or transfer by FCHS to any other party will immediately render the present Assignment null and void and the title
to any patent rights herein assigned to FCHS shall revert to Bittar.

 

FCHS shall, promptly
after the execution hereof, cause the present assignment to be recorded in the U.S. Patent and Trademark Office

 

This assignment shall be construed
in accordance with the laws of the State of Florida, U.S.A. Both parties agree to submit to the jurisdiction and accept service
of process by the Courts of the State of Florida and the U.S. Federal District Court in Florida. 

 

This Agreement is dated as of and effective
August 28, 2013.

 

 

	First Choice Healthcare Solutions, Inc.	 	Donald Bittar.

 

 

	/s/ Christian C.
Romandetti	 	 /s/ Donald A. Bittar
	By: Christian C. Romandetti	 	By: Donald A. Bittar

PresidentExhibit 10.24

 

AMENDMENT TO LOAN AGREEMENT

 

THIS AMENDMENT TO LOAN AGREEMENT (this “Amendment”)
is made and entered into as of the 28th of August, 2013, by and among MTI Capital, LLC, a Delaware limited liability
company (“Lender”) and First Choice Healthcare Solutions, Inc.,  a Delaware corporation (“Borrower”).

 

RECITALS

 

		A.	Borrower and Lender are parties to that certain Loan Agreement, dated on or about May 1, 2013 the “Loan Agreement”,
pursuant to which Lender made available to Borrower a line or credit in the amount of Two Million Dollars ($2,000,000) for the
purpose of financing the general corporate purposes of the Borrower.

 

		B.	The Borrower has agreed to change the conversion rate and in consideration of such change the parties have agreed to continue
working under the Loan Agreement.

 

		C.	Capitalized terms used but not defined herein shall have the meanings given to them in the Loan Agreement.

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the
premises and covenants contained herein, Borrower and Lender do hereby agree to the following amendments to the Loan Agreement:

 

Section 1The sixth paragraph of the Loan Agreement
shall be deleted in its entirely and replaced with the following:

 

Holder, at its sole opinion, may convert
all or any portion of the principal (or added principal) into shares of First Choice Healthcare Solutions, Inc. (OCTBB: FCHS) that
the Maker has the right to have issued to the Holder (or its assigns), said common stock based upon a price of $.45 per share (the
“Shares”). Holder shall exercise its option by completing the form of Conversion Notice attached hereto as Exhibit
A. In connection with the issuance of the Shares, the Holder represents and warrants the following to the Maker:

 

Section 2Representations and Warranties.
Borrower makes all representations and warranties set forth in the Loan Agreement as of the date hereof and confirms that they
are true and correct in all material respects and that there is no Event of Default outstanding.

 

Section 3 Miscellaneous.

 

(a)               
Amendments. Neither this Amendment nor any provision hereof may be changed, waived, discharged, or terminated
orally, but only by instrument in writing signed by all of parties to this Amendment.

 

    	 

    	 

    

 

(b)              
Counterparts; PDFs. This Amendment may be executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instruments. Delivery of an executed signature page by facsimile
or PDF shall be as effective as delivery of a manually executed counterpart hereof.

 

 

IN WITNESS WHEREOF, Borrower and Lender
have hereunto caused these presents to be executed on the first above written.

 

	LENDER	 	BORROWER
	 	 	 
	MTI Capital, LLC	 	First Choice Healthcare Solutions, Inc.

 

	 	 	 
	By: /s/ Frank Sarro	By: /s/ Christian C. Romandetti
	Name: Frank Sarro	 	Name: Christian C. Romandetti
	Title: Member	 	Title : Prsident

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00228-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00228-of-00352.parquet"}]]